A first-in-human phase 1 clinical gene therapy trial for the treatment of heart failure using a novel rationally designed cardiotropic adeno-associated vector. (31st December 2022) - Alvisi, Monica; Henry, Timothy; Chung, Eugene; Traverse, Jay; Ervin, Leigh; Krupa, Shiva; Sadek, Hesham; Jiang, Canwen; Mikhail, Sheila; Haghighi, Kobra; Kranias, Evangelia; Samulski, Jude; et al.